Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048

BACKGROUND: Vaginal rings (VRs) are a promising approach for sustained delivery of antiretroviral (ARV) medication to prevent human immunodeficiency virus (HIV) infection in women. Combination ARV VRs could increase efficacy. METHODS: MTN-028, a phase 1 trial in 19 HIV-uninfected women, evaluated 2...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Liu, Albert Y, Zhang, Jingyang, Anderson, Peter L, Wagner, Theresa, Pan, Zhenyu, Peda, Melissa, Gomez, Kailazarid, Beamer, May, Jacobson, Cindy, Strizki, Julie, Dezzutti, Charlene S, Piper, Jeanna M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Articles and Commentaries
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424086/
https://ncbi.nlm.nih.gov/pubmed/30289444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy652
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars